Sinopharm Group to host Q3 2025 earnings briefing

China National Medicines Corp (Sinopharm Group) has announced it will hold an online investor briefing for its 2025 third-quarter results on November 27, 2025, from 3:00 p.m. to 4:00 p.m. The event will take place on the Shanghai Stock Exchange Roadshow Center platform, allowing for interactive Q&A sessions.

Shareholders can submit questions in advance from November 20 to November 26, 2025, until 4:00 p.m., via the "Question Pre-collection" section on the roadshow center website or by emailing gygfzqb@sinopharm.com. The company will address commonly raised concerns during the briefing. Key management, including chairman Liu Yuetao and cfo Chen Fei, are expected to attend.

The briefing aims to provide a comprehensive overview of Sinopharm Group's operational achievements and financial status for the third quarter of 2025, following the release of its third-quarter report on October 22, 2025. Investors can view the meeting's details and content on the Roadshow Center after the event.